Logo image of TVGN

TEVOGEN BIO HOLDINGS INC (TVGN) Stock Overview

USA - NASDAQ:TVGN - US88165K1016 - Common Stock

0.7381 USD
+0.01 (+1.96%)
Last: 10/9/2025, 9:44:22 PM
0.7381 USD
0 (0%)
Pre-Market: 10/10/2025, 4:03:56 AM

TVGN Key Statistics, Chart & Performance

Key Statistics
52 Week High3.09
52 Week Low0.64
Market Cap145.19M
Shares196.71M
Float40.60M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.38
PE1.94
Fwd PEN/A
Earnings (Next)11-10 2025-11-10
IPO11-04 2021-11-04
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


TVGN short term performance overview.The bars show the price performance of TVGN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

TVGN long term performance overview.The bars show the price performance of TVGN in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of TVGN is 0.7381 USD. In the past month the price decreased by -16.48%. In the past year, price increased by 94.44%.

TEVOGEN BIO HOLDINGS INC / TVGN Daily stock chart

TVGN Latest News, Press Relases and Analysis

TVGN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.78 407.53B
AMGN AMGEN INC 13.55 159.05B
GILD GILEAD SCIENCES INC 15.08 144.85B
VRTX VERTEX PHARMACEUTICALS INC 24.49 106.37B
REGN REGENERON PHARMACEUTICALS 12.49 60.40B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.90B
ARGX ARGENX SE - ADR 86.83 49.26B
ONC BEONE MEDICINES LTD-ADR 5.42 36.88B
INSM INSMED INC N/A 34.75B
BNTX BIONTECH SE-ADR N/A 25.12B
NTRA NATERA INC N/A 23.75B
BIIB BIOGEN INC 9.34 21.93B

About TVGN

Company Profile

TVGN logo image Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company is headquartered in Warren, New Jersey and currently employs 18 full-time employees. The company went IPO on 2021-11-04. The firm is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.

Company Info

TEVOGEN BIO HOLDINGS INC

15 Independence Boulevard, Suite #210

WARREN NEW JERSEY US

Employees: 18

TVGN Company Website

Phone: 16468078832

TEVOGEN BIO HOLDINGS INC / TVGN FAQ

What is the stock price of TEVOGEN BIO HOLDINGS INC today?

The current stock price of TVGN is 0.7381 USD. The price increased by 1.96% in the last trading session.


What is the ticker symbol for TEVOGEN BIO HOLDINGS INC stock?

The exchange symbol of TEVOGEN BIO HOLDINGS INC is TVGN and it is listed on the Nasdaq exchange.


On which exchange is TVGN stock listed?

TVGN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for TEVOGEN BIO HOLDINGS INC stock?

7 analysts have analysed TVGN and the average price target is 10.2 USD. This implies a price increase of 1281.93% is expected in the next year compared to the current price of 0.7381. Check the TEVOGEN BIO HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is TEVOGEN BIO HOLDINGS INC worth?

TEVOGEN BIO HOLDINGS INC (TVGN) has a market capitalization of 145.19M USD. This makes TVGN a Micro Cap stock.


How many employees does TEVOGEN BIO HOLDINGS INC have?

TEVOGEN BIO HOLDINGS INC (TVGN) currently has 18 employees.


What are the support and resistance levels for TEVOGEN BIO HOLDINGS INC (TVGN) stock?

TEVOGEN BIO HOLDINGS INC (TVGN) has a support level at 0.67 and a resistance level at 0.75. Check the full technical report for a detailed analysis of TVGN support and resistance levels.


Should I buy TEVOGEN BIO HOLDINGS INC (TVGN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TEVOGEN BIO HOLDINGS INC (TVGN) stock pay dividends?

TVGN does not pay a dividend.


When does TEVOGEN BIO HOLDINGS INC (TVGN) report earnings?

TEVOGEN BIO HOLDINGS INC (TVGN) will report earnings on 2025-11-10.


What is the Price/Earnings (PE) ratio of TEVOGEN BIO HOLDINGS INC (TVGN)?

The PE ratio for TEVOGEN BIO HOLDINGS INC (TVGN) is 1.94. This is based on the reported non-GAAP earnings per share of 0.38 and the current share price of 0.7381 USD. Check the full fundamental report for a full analysis of the valuation metrics for TVGN.


What is the Short Interest ratio of TEVOGEN BIO HOLDINGS INC (TVGN) stock?

The outstanding short interest for TEVOGEN BIO HOLDINGS INC (TVGN) is 6.38% of its float. Check the ownership tab for more information on the TVGN short interest.


TVGN Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to TVGN. When comparing the yearly performance of all stocks, TVGN is one of the better performing stocks in the market, outperforming 84.73% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TVGN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to TVGN. TVGN has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TVGN Financial Highlights

Over the last trailing twelve months TVGN reported a non-GAAP Earnings per Share(EPS) of 0.38. The EPS increased by 375% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA 337.72%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%640%
Sales Q2Q%N/A
EPS 1Y (TTM)375%
Revenue 1Y (TTM)N/A

TVGN Forecast & Estimates

7 analysts have analysed TVGN and the average price target is 10.2 USD. This implies a price increase of 1281.93% is expected in the next year compared to the current price of 0.7381.


Analysts
Analysts82.86
Price Target10.2 (1281.93%)
EPS Next YN/A
Revenue Next YearN/A

TVGN Ownership

Ownership
Inst Owners2.57%
Ins Owners79.36%
Short Float %6.38%
Short Ratio2.86